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Abstract
Background: Control of cytosolic calcium plays a key role in airway myocyte function. Changes
in intracellular Ca2+ stores can modulate contractile responses, modulate proliferation and regulate
synthetic activity. Influx of Ca2+ in non excitable smooth muscle is believed to be predominantly
through store operated channels (SOC) or receptor operated channels (ROC). Whereas agonists
can activate both SOC and ROC in a range of smooth muscle types, the specific trigger for SOC
activation is depletion of the sarcoplasmic reticulum Ca2+ stores. The mechanism underlying SOC
activation following depletion of intracellular Ca2+ stores in smooth muscle has not been identified.
Methods: To investigate the roles of the STIM homologues in SOC activation in airway myocytes,
specific siRNA sequences were utilised to target and selectively suppress both STIM1 and STIM2.
Quantitative real time PCR was employed to assess the efficiency and the specificity of the siRNA
mediated knockdown of mRNA. Activation of SOC was investigated by both whole cell patch
clamp electrophysiology and a fluorescence based calcium assay.
Results: Transfection of 20 nM siRNA specific for STIM1 or 2 resulted in robust decreases (>70%)
of the relevant mRNA. siRNA targeted at STIM1 resulted in a reduction of SOC associated Ca2+
influx in response to store depletion by cyclopiazonic acid (60%) or histamine but not bradykinin.
siRNA to STIM2 had no effect on these responses. In addition STIM1 suppression resulted in a
more or less complete abrogation of SOC associated inward currents assessed by whole cell patch
clamp.
Conclusion:  H e r e  w e  s h o w  t h a t  S T I M 1  a c t s  a s  a  k e y signal for SOC activation following
intracellular Ca2+ store depletion or following agonist stimulation with histamine in human airway
myocytes. These are the first data demonstrating a role for STIM1 in a physiologically relevant, non-
transformed endogenous expression cell model.
Background
Control of intracellular calcium is critical to regulation of
smooth muscle function in many tissues. The relative con-
tribution of SOC to the control of intracellular Ca2+ varies
between different types of smooth muscle, with SOC
being particularly prominent in airway myocytes. The
contractile/relaxant state of the airway myocyte is a key
determinant of airway calibre thus contributing to bron-
choconstriction in diseases such as asthma. Previous stud-
ies have demonstrated that the contractile response of
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airway myocytes is dependent initially upon release of
intracellular Ca2+  from the sarcoplasmic reticulum
(reviewed in [1]) but that sustained contraction is
dependent upon influx from extracellular sources. Two
mechanisms have been proposed to account for this
influx in airway myocytes involving either activation of
SOC or ROC. In contrast to vascular smooth muscle, L
type voltage dependent calcium channels (VDCCs)
appear to play a negligible role in control of Ca2+ entry [2].
In previous work we have demonstrated the expression of
a number of TRP homologues including TRPC1, 3, 4 and
6 in cultured human airway myocytes and lung tissue and
have suggested that TRPC6 may play an important role
(probably together with other TRPC homologues includ-
ing TRPC3 [3]) in contributing to agonist induced ROC
activity [4].
SOC activation in many cell types including smooth mus-
cle is known to involve depletion of the intracellular sar-
coplasmic reticulum Ca2+ stores. Contractile agonists such
as acetylcholine, histamine and bradykinin may vary in
their ability to differentially activate ROC or SOC
although all agonists are known to induce activation of
phospholipase C with consequent IP3  mediated Ca2+
release from the intracellular stores. The mechanism
underlying signalling for subsequent Ca2+  influx in
response to store depletion, and hence refilling of the sar-
coplasmic reticulum Ca2+ stores, remains unknown. In the
current study we have set out to define the signals for SOC
activation in human airway myocytes following both
store depletion and agonist activation by spasmogens.
Using RNA interference techniques STIM (stromal interac-
tion molecule) 1 has been shown to play a role in SOC
induced calcium entry in Drosophilia S2 cells, Jurkat T
cells [5] and Hela cells [6] with the latter study also impli-
cating a role for STIM2. In particular, STIM1 appears to be
a major activator of calcium release activated calcium
channels (ICRAC) in T lymphocytes via a mechanism which
has been proposed to involve translocation of STIM1
from endoplasmic reticulum like sites to the cell mem-
brane [7]. We therefore hypothesised that homologues of
STIM may play a role in SOC activation in smooth muscle.
To address this hypothesis we used specific siRNA
sequences to suppress both STIM1 and STIM2.
Methods
Cells
Human bronchial tissue was obtained from patients with-
out a history of asthma. Human airway smooth muscle
(HASM) cells were isolated and cultured as previously
described [8]. Ethical approval for these studies was
obtained from the Nottingham local ethical research com-
mittee. All subjects from whom tissue was obtained gave
written consent. Primary human bronchial epithelial cells
were obtained from Cambrex Bioscience (MD, USA) and
grown in accordance with suppliers protocols. Cells at
passage 4 were differentiated at an air-liquid interface on
polyester tissue culture inserts (Corning, Costar) as
described in a previous published method [9].
Transfection of siRNAs
siRNAs, including the scrambled siRNA control were pur-
chased from Ambion (Huntingdon, Cambridge, UK).
STIM1 siRNA (AAGGGAAGACCTCAATTACCA) was pre-
designed from Ambion, STIM2 siRNA (AACTGAGAAG-
CAGTTGGTCTG) designed by Roos and colleagues [5].
Cells were transfected with siRNA (1–50 nM) in serum
free medium over a period of 6 h, the medium was then
aspirated and replaced with serum containing medium for
a further period of 42 h. The transfection reagent used was
Lipofectamine 2000 (Invitrogen, Paisley, UK) at a final
concentration of 2 µl/ml.
Total RNA extraction and reverse transcriptase PCR
Total RNA was isolated from pelleted cells using the RNe-
asy mini kit (Qiagen, West Sussex, UK) as per manufactur-
ers' instructions. To examine for STIM1 and STIM2
expression, RNA was reverse-transcribed using Superscript
II reverse transcriptase (Invitrogen) and random hexamers
(Invitrogen). PCR was performed using specific primers
against STIM1 (Forward; AGGCAGTCCGTAACATCCAC,
Reverse; CTTCAGTCCGTAACATCCAC) and STIM2 (For-
ward; TCCCTGCATGTCACTGAGTC, Reverse; GGGAAGT-
GTCGTTCCTTTGA). Cycling was performed 35 times;
94°C, followed by 55°C (annealing temperature), then
72°C (all for 90 seconds) followed by 10 mins at 72°C.
PCR products were visualized by ethidium bromide stain-
ing and confirmed by direct sequencing.
Real-Time PCR (Taqman)
siRNA targeted mRNA knockdown was measured using
real time, quantitative PCR (Taqman). Gene specific prim-
ers and probes against STIM1 and STIM2 were designed
using Primer Express™ software (Applied Biosystems, Fos-
ter City, CA) and using 18s RNA as the reference gene
(Applied Biosystems). All probes were MGB probes,
labeled with a 5'-reporter dye FAM and a non fluorescent
quencher. Each sample was run in duplicate and mRNA
knockdown was measured from mRNA obtained from 3
separate experiments. The relative expression of the target
gene was calculated using the comparative method (2-
∆∆Ct) [10].
Primer and probe sequences:
STIM-1 forward primer: AAGGCTCTGGATACAGT-
GCTCTTT
reverse primer: AGCATGAAGTCCTTGAGGTGATTATRespiratory Research 2006, 7:119 http://respiratory-research.com/content/7/1/119
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probe: CTCCTCTCTTGACTCGC
STIM-2 forward primer: ACGACACTTCCCAGGATAGCA
reverse primer: GACTCCGGTCACTGATTTTCAAC
probe: TGCACGAACCTTCATT
Measurement of [Ca2+]i
HASMs (passage 4–5) were plated in black walled, clear
bottom 96 well plates and loaded with Fluo-4AM (Molec-
ular probes) for 1 hour at room temperature in culture
medium (DMEM) supplemented with 10% FCS and 2.5
mM probenecid (Sigma Chemical Co, Poole, Dorset, UK).
Cells were then washed with Hanks' balanced saline solu-
tion containing 10 mM Hepes, 2.5 mM probenecid, 0.1
mM CaCl2 and 1 mM MgCl2. The fluorescence was contin-
uously recorded at wavelengths of 485 nm excitation and
520 nm emission using a Flexstation (Molecular Devices,
Wokingham, UK). Cells were treated with 10 µM cyclopi-
azonic acid (final concentration) for 4 minutes followed
by the addition of 1.9 mM CaCl2 (2 mM final concentra-
tion). For agonist induced Ca2+ responses, cells were stim-
ulated with bradykinin (1 µM) or histamine (100 µM
final concentration) for 4 minutes in 0.1 mM CaCl2 buffer
followed by the addition of 1.9 mM CaCl2. Data are pre-
sented as changes in fluorescence intensity (FI) compared
with the baseline, the area under the curve was used as an
estimation of changes in [Ca2+]i.
Patch-clamp electrophysiology
The conventional whole-cell patch-clamp technique [11]
was employed to record store operated inward currents in
single HASM cells with an EPC-10 double amplifier and
Patchmaster version 2.10 software (HEKA, Lambrecht,
Germany). The compositions of the internal and external
solutions are as follows; Standard Internal Solution; 110
mM Cs-methanesulfonate, 25 mM CsCl, 2 mM MgCl2, 10
mM EGTA, 30 mM HEPES, 3.62 mM CaCl2. External Solu-
tion: 140 mM NaCl, 5 mM CsCl, 1 mM MgCl2, 10 mM D-
Glucose, 10 mM HEPES, CaCl2 (as indicated). K+ was
replaced by Cs+ in both external and internal solutions to
block K+ currents and Cl- was replaced by an equal molar
concentration of methanesulfonate to minimize Cl- cur-
rents. Nifedipine (5 µM) was included in the external
solution. Pipettes were drawn from borosilicate glass and
had resistances of 5–8 MΩ when filled with internal solu-
tion. HASM cells were placed directly into the cell cham-
ber, allowed to settle and then were continuously
perfused with external solution at a constant speed of 6
ml/min. Experimental drugs were delivered through a
puffer pipette positioned 50 µm around the cells. Cells
were held at a membrane potential of -60 mV and current-
voltage relationships were analysed every 5s from voltage
ramps from -100 to +100 mV at a rate of 0.5 Vs-1. Currents
were filtered at 1 kHz and sampled at 4 KHz. Individual
cell current densities were calculated by dividing peak cur-
rent amplitude at maximum activation of inward current
(at -100 mV) by cell capacitance.
Immunostaining
HASMs grown on coverslips, transfected with either 20
nM scrambled siRNA or 20 nM STIM1 siRNA were fixed
with 4% formaldehyde. Cells were permeabilized (0.5%
TritonX-100) and blocked with 20% goat serum in PBS
for 20 min. Cells were incubated with primary antibody
(mouse, anti-human STIM1 mAb (1:100) (BD Bio-
sciences, Pharmingen) overnight at 4°C followed by labe-
ling with Alexa fluor 488 (Molecular probes). Cells were
visualized on a Zeiss LS 510 confocal microscope (Hert-
fordshire, UK).
Statistical analysis
Averaged data are presented as mean ± sem. Where appro-
priate, statistical significance was assessed by unpaired
Students T tests or one-way ANOVA followed by the Dun-
nets test for multiple group comparisons. Data were con-
sidered significant at *P < 0.05 or **P < 0.01.
Results and discussion
Initially we assessed the expression of the two known
human homologues STIM1 and STIM2 in cells relevant to
airway function (figure 1a). Both STIM1 and STIM2 are
highly expressed in primary cultures of airway myocytes
and also in bronchial epithelial cells. We therefore utilised
specific siRNA sequences to target and selectively suppress
both STIM1 and STIM2 in order to investigate the role of
these putative signals in SOC activation in airway myoc-
tyes. siRNAs targeted at STIM1 and STIM2 produced dose
dependent inhibition of the relevant target molecule with-
out significant effects upon expression of either the other
STIM homologue or 18sRNA (figure 1c &1d). Transfec-
tion of 20 nM siRNA specific for STIM1 or 2 resulted in
robust decreases (>70%) of the relevant STIM mRNA. The
ability to inhibit protein expression was evaluated by con-
focal microscopy for STIM1 alone (in view of functional
data shown below) with marked inhibition of protein
expression being evident following 48 hours exposure to
the relevant siRNA (figure 1b).
We next evaluated the ability of siRNA targeted to STIM1
and STIM2 to inhibit SOC using a fluorescence assay uti-
lising Fluo-4AM, designed to measure changes in intracel-
lular free calcium concentration ([Ca2+]i) in monolayers
of cultured human airway myocytes. SOC mediated Ca2+
influx was induced by depletion of the sarcoplasmic retic-
ulum Ca2+ store using a combination of low external
Ca2+(0.1 mM) and incubation with the SERCA inhibitor
cyclopiazonic acid (CPA, 10 µM). Incubation of airway
myocytes in low Ca2+ in the presence of CPA resulted in anRespiratory Research 2006, 7:119 http://respiratory-research.com/content/7/1/119
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initial small rise in cytosolic Ca2+ indicative of store deple-
tion. Re-addition of extracellular Ca2+ resulted in rapid
influx into the cell through SOCs. siRNA targeted at
STIM1 resulted in a dose-dependent reduction of SOC
associated Ca2+  influx (figure 2a &2b). Using 20 nM
STIM1 siRNA, CPA dependant Ca2+ influx was reduced by
60% compared to control cells. In contrast siRNA targeted
at STIM2 had little effect upon SOC activation following
store depletion (figure 2c &2d). Control cells initiated
both CPA dependent and independent Ca2+ influx (figure
2e) upon Ca2+ re-addition. The mechanism of this basal
Ca2+ entry is unknown but previous studies in other cell
types suggest that this passive Ca2+ leak may not be due to
SOC mediated influx [5]. In keeping with this, CPA inde-
pendent/basal Ca2+ influx was insensitive to siRNA medi-
ated STIM1 suppression (data not shown).
We next used whole cell patch clamp electrophysiology
approaches to confirm that siRNA targeted at STIM1 but
not STIM2 is able to inhibit SOC activation. SOC currents
were activated by reducing external Ca2+ and application
of 10 µM CPA. Current density was calculated by dividing
peak current amplitude by cell capacitance; the average
capacitance of the cells was 50.7 ± 4.1 pF (mean ± sem).
SOC currents were induced by voltage ramps at a rate of
0.5 mV·ms-1 from a holding potential of -60 mV. Inward
currents (SOC currents) measured at -100 mV were then
compared. Changes in current density of SOC are illus-
trated in Figure 3(a–c): preincubation with siRNA targeted
to STIM1 almost completely abrogated SOC currents
whereas siRNA targeted at STIM2 had no significant effect
on SOC activation in these cells. Figure 3b shows the aver-
aged current-voltage (I-V) relationships of the steady-state
Expression and siRNA mediated knockdown of STIM Figure 1
Expression and siRNA mediated knockdown of STIM. (a) Expression of STIM1 and STIM2 in human airway myocytes and cul-
tured human bronchial epithelial cells (hbec) using RT-PCR. PCR products were sequenced to confirm expression. (b) Tiled 
arrays of immunofluorescent staining of STIM-1 in HASM cells treated with either 20 nM scrambled siRNA (left) or 20 nM 
siRNA targeted at STIM1 (right). The intensity of STIM1 staining was decreased in cells treated with STIM1 siRNA. (c) siRNA 
targeted knockdown of STIM1 mRNA assessed by quantitative PCR. Cells transfected with STIM-1 siRNA dose dependently 
reduced STIM1 mRNA levels (76.9 ± 7.5% at 20 nM) without affecting STIM2 mRNA. (d) siRNA targeted knockdown of STIM2 
mRNA. Cells transfected with STIM2 siRNA reduced STIM2 mRNA levels (70 ± 8.3% at 20 nM) without affecting STIM1. In 
addition, transfection of 20 nM scrambled, non-silencing siRNA had no effect on STIM expression.
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SOC current (ie addition of 10 µM CPA in Ca2+ free
buffer). The STIM1 suppressed cells showed a reduced
SOC inward current compared with cells treated with
scrambled or STIM2 siRNA sequences. We also noticed a
change in the reversal potential in the STIM1 suppressed
cells towards a more negative potential: the significance of
this is uncertain but similar findings on ICRAC currents
have been reported using EF-hand mutants of STIM1 in
RBL cells [12].
The consequences of inhibiting STIM1 and STIM2 expres-
sion on agonist mediated Ca2+ entry in human airway
myocytes are shown in figure 4. We have previously
shown histamine induced Ca2+ responses to be H1 recep-
tor mediated in these cells. Under conditions of low extra-
cellular Ca2+ the sustained rise in intracellular Ca2+ seen
following agonist stimulation is reduced, an effect mim-
icked by a range of di and tri-valent cations including
Ni2+, La3+ and Gd3+ and also by the putative ROC inhibi-
Suppression of STIM1 results in decreased store operated calcium influx Figure 2
Suppression of STIM1 results in decreased store operated calcium influx. (a) A representative raw trace illustrating the 
changes in [Ca2+]i (presented as fluorescence intensity (FI)) in HASMs treated with STIM-1 siRNA. CPA (10 µM) was added to 
the cells in the presence of low extracellular Ca2+ (0.1 mM) followed by the restoration of 2 mM Ca2+ as indicated. (b) Sum-
mary of the data illustrated in (a) showing averaged changes in fluorescence after 2 mM Ca2+ restoration. (c) A representative 
trace illustrating changes in [Ca2+]i in HASMs treated with STIM-2 siRNA following the same protocol. (d) Summary of the 
data illustrated in (c) showing averaged changes in fluorescence after 2 mM Ca2+ restoration. The summarized data (c & d) are 
shown following subtraction of CPA independent (basal) calcium influx (measured as the fluorescence change upon addition of 
2 mM Ca2+ to cells not pre-treated with CPA). (e) An experimental trace illustrating CPA independent (basal) Ca2+ influx. 
Results are expressed as % changes ± sem compared to control and represent averaged data from 4 separate experiments. 
Data are indicated as statistically significant with *P < 0.05 and **P < 0.01.
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tor SKF96365 [2]. Previously however it has been impos-
sible to disassociate the SOC and ROC components of the
agonist induced Ca2+ response to agonist. Following pre-
incubation with siRNA targeted at STIM1 we observed a
significant reduction in the magnitude of Ca2+  influx
induced by histamine (figure 4d &4f). These results sug-
gest that under the conditions tested the STIM1 mediated
SOC component may account for >50% of the Ca2+ influx
induced by histamine. We have previously shown hista-
mine to induce a robust activation of phospholipase C in
these cells which initiates IP3 mediated Ca2+ release from
intracellular stores [8]. However there is evidence of ago-
nist specific differences in the ability to activate SOC and
ROC in airway myocytes: the ability of siRNA targeted
against STIM1 to inhibit bradykinin induced Ca2+ influx
was limited (figure 4a and 4c) and markedly less than
inhibition seen when histamine was used as the agonist.
This may suggest that stimulation of cognate receptors by
these agonists vary in their ability to activate SOC or ROC
(figure 4). The other possibility is that the difference may
reflect variation in the extent of phospholipase C activa-
tion: the maximum inositol phospholipid hydrolysis
response to bradykinin seen in these cells is around 3
times greater than the maximal response to histamine [8].
The mechanism whereby STIM1 is able to activate SOC in
airway myocytes remains to be determined. The STIM
genes encode type 1 transmembrane proteins that can
potentially form hetero or homo-oligomers via coiled-
coiled interactions [13,14]. The NH2 terminus contains an
EF-hand Ca2+  binding motif which is thought to be
responsible for the detection of Ca2+ depletion in stores
[6,7,12]. STIM1 is expressed in both plasma and intracel-
lular membranes [13] and the EF hand is thought to be
Reduced SOC activated inward current in STIM1 suppressed cells compared with control and STIM2 suppressed cells assessed  by whole cell patch clamp Figure 3
Reduced SOC activated inward current in STIM1 suppressed cells compared with control and STIM2 suppressed cells assessed 
by whole cell patch clamp. (a) A time course of current density (measured at -100 mV), each point represents mean data ± 
sem of all cells in each group; control cells treated with scrambled siRNA (black circles, n = 16), STIM1 suppressed cells (blue 
squares, n = 10) and STIM2 suppressed cells (red triangles, n = 12). (b) Current-voltage (I-V) relationships at the steady-state 
SOC current (ie addition of 10 µM CPA in nominally Ca2+ free buffer) and represents averaged data from all cells of each 
experimental group. (c) A bar chart illustrating peak CPA sensitive current density (measured at -100 mV) of cells treated with 
scrambled control, STIM-1 or STIM-2 siRNA. Data are indicated as statistically significant with **P < 0.01.
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located outside the cell or in the lumen of intracellular
stores. It is conceivable that STIM proteins may interact
(possibly through coiled coil domains) between the two
membranes providing the vital link between intracellular
stores and the plasma membrane [5]. Other models have
been suggested including translocation of STIM1 from the
endoplasmic reticulum to the plasma membrane [7]
where STIM1 could directly activate SOC channels, or the
involvement of STIM1 in the production of an unidenti-
fied Ca2+ influx factor [15].
The exact molecular identity of SOC in airway myocytes
remains to be determined although potential candidates
include a range of TRP homologues [3,16,17]. At present
there are no specific tools to inhibit these channels
directly and such approaches may be complicated by the
formation of channels formed of heteromeric subunits.
Conclusion
Our data clearly implicates a role for STIM1 in SOC acti-
vation in airway myocytes providing for the first time
Suppression of STIM1 results in reduced Ca2+ influx in response to histamine but not bradykinin Figure 4
Suppression of STIM1 results in reduced Ca2+ influx in response to histamine but not bradykinin. (a & b) Representative traces 
illustrating bradykinin induced [Ca2+]i changes in HASMs treated with 20 nM STIM1 siRNA (a) and 20 nM STIM2 siRNA (b) 
compared with control. (c) Summary of data represented in (a & b) showing average changes in fluorescence after 2 mM Ca2+ 
re-addition. (d & e) Representative traces illustrating histamine induced changes in [Ca2+]i in HASMs treated with 20 nM 
STIM1 siRNA (d) and 20 nM STIM2 siRNA (e) compared with control. (f) Summarized data from (d and e) showing average flu-
orescence changes after 2 mM Ca2+ re-addition. Bradykinin (1 µM) or Histamine (100 µM) was added to cells in low extracel-
lular Ca2+ (0.1 mM) followed by the restoration of 2 mM Ca2+ as indicated. The summarized data (c & f) are shown with 
subtraction of agonist independent (basal) calcium influx. Results are expressed as % changes ± sem compared to control and 
represent averaged data from at least 3 experiments. Data are indicated as statistically significant with *P < 0.05 and **P < 0.01.
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molecular insight into this key signalling pathway in
smooth muscle. Given the importance of control of intra-
cellular Ca2+ to airway smooth muscle contraction STIM1
may provide a potential therapeutic target for diseases
characterised by increased smooth muscle contractility
such as asthma. However, one note of caution must be
added in that STIM1 was initially identified as a candidate
tumour suppressor gene [18] and the consequences there-
fore of long term inhibition of STIM1 expression need to
be explored further.
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